APA (7th ed.) Citation

Feng, C., Li, P., Liu, P., Wang, B., Li, J., & Liu, P. (2024). LMAN2 Promotes Breast Cancer Tumorigenesis and Drug Resistance by Interacting With MAPK9 via Activation of the MAPK Pathway. Cancer Medicine, 13(23), 1. https://doi.org/10.1002/cam4.70448

Chicago Style (17th ed.) Citation

Feng, Chen, Pingping Li, Pengtao Liu, Bo Wang, Juan Li, and Peijun Liu. "LMAN2 Promotes Breast Cancer Tumorigenesis and Drug Resistance by Interacting With MAPK9 via Activation of the MAPK Pathway." Cancer Medicine 13, no. 23 (2024): 1. https://doi.org/10.1002/cam4.70448.

MLA (9th ed.) Citation

Feng, Chen, et al. "LMAN2 Promotes Breast Cancer Tumorigenesis and Drug Resistance by Interacting With MAPK9 via Activation of the MAPK Pathway." Cancer Medicine, vol. 13, no. 23, 2024, p. 1, https://doi.org/10.1002/cam4.70448.